Valneva Statistics
NASDAQ: VALNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.87+0.01 (+0.17%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Valneva by the numbers
Valneva has a market capitalization of $556.6 million based on 94.82M shares outstanding. With trailing EPS of $-2.10, Valneva is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.6% below its 50-day average and 17.7% below its 200-day average.
Average daily trading volume is 77.94K shares, or about $457,502 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VALN valuation vs. peer median
| Metric | VALN | Peer median | Difference |
|---|---|---|---|
| Market cap | $556.61M | $538.16M | +3% |
| Avg. volume | 77.94K | 1.15M | -93% |
Peer median across 8 companies: ETRA, RGNX, DBVT, ALLO, PROK, AUTL, TECX, AURA.
Valuation
- Market cap
- $556.61M
- Forward P/E
- 4.93
- EPS (TTM)
- $-2.10
- Shares outstanding
- 94.82M
Price and trading
- Previous close
- 5.86
- Open
- 5.87
- Day range
- 5.87 – 5.99
- 52-week range
- 4.75 – 12.18
- 52-week change
- -44.88%
- Beta
- —
- Volume
- 14.80K
- Average volume
- 77.94K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 556.61M
- Forward Pe
- 4.93
- Eps
- -2.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.18
- Week52 Low
- 4.75
- Avg Volume
- 77,939.00
- Shares Outstanding
- 94.82M
- Ma50
- 6.22
- Ma200
- 7.13
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -51.81%
- Pct From52w Low
- 23.58%